Literature DB >> 2125490

Control of mucin synthesis: the peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose:N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase.

I Brockhausen1, G Möller, G Merz, K Adermann, H Paulsen.   

Abstract

Synthetic O-glycopeptides containing one or two GalNAc residues attached to Ser or Thr were used as substrates to investigate the effect of peptide structure on the activity of crude preparations of UDP-Gal:GalNAc alpha-R beta 3-Gal-transferase from pig stomach and pig and rat colonic mucosa and of a partially purified enzyme preparation from rat liver. High-performance liquid chromatography used to separate enzyme products revealed that uncharged glycopeptides with an acetyl group at the amino-terminal end and a tertiary butyl or an amide group at the carboxy-terminal end were resistant to proteolysis in crude preparations. The activity of beta 3-Gal-transferase varied with the sequence and length of the peptide portion of the substrate, the presence of protecting groups, the attachment site of GalNAc, and the number of GalNAc residues in the substrate. The presence and position of Pro had little effect on enzyme activity; ionizing groups near the GalNAc unit interfered with enzyme activity. Since the GalNAc-Thr moieties in many of these O-glycopeptides have been shown to assume similar rigid conformations, the variation in enzyme activity indicates that the beta 3-Gal-transferase recognizes both the peptide and carbohydrate moieties of the substrate. Rat and pig colonic mucosal homogenates contain beta 3- and beta 6-GlcNAc-transferases that synthesize respectively O-glycan core 3 (GlcNAc beta 3GalNAc alpha-R) and core 4 [GlcNAc beta 6(GlcNAc beta 3)GalNAc alpha-R]. These enzymes also showed variations in activity with different peptide structures; these effects did not parallel those observed with beta 3-Gal-transferase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125490     DOI: 10.1021/bi00496a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

Review 1.  Structure, biosynthesis, and function of salivary mucins.

Authors:  A M Wu; G Csako; A Herp
Journal:  Mol Cell Biochem       Date:  1994-08-17       Impact factor: 3.396

Review 2.  O-linked glycosylation in the mammary gland: changes that occur during malignancy.

Authors:  J M Burchell; A Mungul; J Taylor-Papadimitriou
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

3.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

Review 4.  Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.

Authors:  Inka Brockhausen
Journal:  EMBO Rep       Date:  2006-06       Impact factor: 8.807

5.  Preferred conformations and dynamics of five core structures of mucin type O-glycans determined by NMR spectroscopy and force field calculations.

Authors:  A Pollex-Krüger; B Meyer; R Stuike-Prill; V Sinnwell; K L Matta; I Brockhausen
Journal:  Glycoconj J       Date:  1993-10       Impact factor: 2.916

6.  Systematic determination of the peptide acceptor preferences for the human UDP-Gal:glycoprotein-alpha-GalNAc beta 3 galactosyltransferase (T-synthase).

Authors:  Cynthia Perrine; Tongzhong Ju; Richard D Cummings; Thomas A Gerken
Journal:  Glycobiology       Date:  2008-12-10       Impact factor: 4.313

7.  Glycosylation of the two O-glycosylated domains of human MUC2 mucin in patients transposed with artificial urinary bladders constructed from proximal colonic tissue.

Authors:  Catherine Robbe-Masselot; Annkatrin Herrmann; Ingemar Carlstedt; Jean-Claude Michalski; Calliope Capon
Journal:  Glycoconj J       Date:  2007-11-15       Impact factor: 2.916

8.  Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzyme.

Authors:  F Reck; E Meinjohanns; M Springer; R Wilkens; J A Van Dorst; H Paulsen; G Möller; I Brockhausen; H Schachter
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

Review 9.  From imino sugars to cancer glycoproteins.

Authors:  H Paulsen; I Brockhausen
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

10.  Acceptor specificities and selective inhibition of recombinant human Gal- and GlcNAc-transferases that synthesize core structures 1, 2, 3 and 4 of O-glycans.

Authors:  Yin Gao; Rajindra P Aryal; Tongzhong Ju; Richard D Cummings; Gagandeep Gahlay; Donald L Jarvis; Khushi L Matta; Jason Z Vlahakis; Walter A Szarek; Inka Brockhausen
Journal:  Biochim Biophys Acta       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.